- The Prescriptions Sold are expected to increase steadily from 72,000 in 2025 to 456,000 in 2033, with an average annual growth rate of 28%.
- The Implied Patients Treated are also projected to grow from 6,000 in 2025 to 38,000 in 2033, with an average annual growth rate of 23%.
- The Market penetration is estimated to reach 1% by 2033, which is a significant improvement from 0.2% in 2025.
- The Wholesale Pricing (WAC) is assumed to increase by 3% every year, from $720 per script in 2025 to $912 per script in 2033.
- The Net pricing (net) is calculated by applying a 25% gross-to-net discount to the WAC, resulting in a net price of $540 per script in 2025 and $684 per script in 2033.
- The Net Sales are forecasted to grow from $38.9 million in 2025 to $311.9 million in 2033, with an average annual growth rate of 30%.
- The COGS are estimated to be 10% of the net sales, which means that they will increase from $7.4 million in 2025 to $46.8 million in 2033.
- The Gross Profit is derived by subtracting the COGS from the net sales, and it is expected to rise from $31.5 million in 2025 to $265.1 million in 2033, with an average annual growth rate of 31%.
- The Gross Margin is calculated by dividing the gross profit by the net sales, and it is projected to improve from 81% in 2025 to 85% in 2033.
- The SG&A are assumed to be a fixed percentage of the net sales, which is set at 20%, except for the first year (2025), where it is higher at 71%, due to launch costs and marketing expenses. This means that the SG&A will increase from $27.5 million in 2025 to $62.4 million in 2033.
- The Royalty is also assumed to be a fixed percentage of the net sales, which is set at 5%, resulting in a royalty payment of $1.9 million in 2025 and $15.6 million in 2033.
- The Operating Income is obtained by subtracting the SG&A and the royalty from the gross profit, and it is forecasted to grow from $2 million in 2025 to $187.2 million in 2033, with an average annual growth rate of 43%.
- Forums
- ASX - By Stock
- BOT
- New Hartley Analyst report on Bot
New Hartley Analyst report on Bot, page-21
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $651.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.3¢ | 35.3¢ | $1.417M | 3.891M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 110000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 457035 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 110000 | 0.355 |
9 | 802288 | 0.350 |
8 | 337711 | 0.345 |
15 | 342337 | 0.340 |
3 | 62985 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 451630 | 6 |
0.365 | 238075 | 2 |
0.370 | 679825 | 2 |
0.375 | 714261 | 12 |
0.380 | 275893 | 11 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online